The mdm2 oncogene is a p53 responsive gene which contains both a p53 independent and a p53 dependent promoter (P1 and P2 respectively). We have utilized ligation mediated PCR genomic footprinting in order to investigate the intra-nuclear binding of p53 to the mdm2 P2 promoter. The DNase I protection pattern in nuclei from murine cells lacking p53 has been compared to the protection pattern in cells containing a temperature sensitive p53-Val135. At 328C p53-Val135 assumes a wild-type conformation while at 378C this p53 is conformationally mutant. We observed clear wild-type p53 dependent protection of the putative p53 response elements (REs) as well as protection of the adjacent TATA box. Interestingly the protection pattern observed with puri®ed wild-type p53 on naked DNA showed less nucleotide sequence protection than the protection observed to be p53 dependent in nuclei. Constitutive DNase I hypersensitivity at both the mdm2 P1 and P2 promoters was detected by indirect Southern blot analysis. DNase I hypersensitivity re¯ects altered chromatin conformations resulting, most likely, from the absence of nucleosomes. Taken together our ®ndings suggest that the mdm2 P2 promoter is maintained in a nucleosome free state which is pre-primed for transcriptional activation by p53.
Introduction p53 is one of the most frequently mutated genes found in human tumors, demonstrating the importance of p53 for the regulation of normal cell growth (Hollstein et al., 1991; Levine et al., 1991) . Wild-type p53 is able to activate transcription from speci®c DNA sequence regions both in vitro and in vivo (Farmer et al., 1992; Funk et al., 1992) . When the site-speci®c DNA binding ability of p53 is abolished the protein is no longer able to direct the activation of speci®c growth controlling genes Zambetti and Levine, 1993) . It is not surprising therefore that most oncogenic p53 mutations reside in the DNA binding domain of the protein (Bargonetti et al., 1993; Pavletich et al., 1993; Wang et al., 1993) and that these mutations result in reduced p53 sequence speci®c DNA binding activity (Bargonetti et al., 1991; Chen et al., 1993a; Kern et al., 1991a,b) . Wild-type p53 binds to diverse DNA sequences containing two adjacent copies of the consensus 5'-Pu Pu Pu C (A/T) (T/A) G Py Py Py-3' (el-Deiry et al., 1992; Funk et al., 1992) . The co-crystal structure of p53 with DNA has shown that some oncogenic mutants aect the conformation of the protein while others result in amino acid substitutions at residues which are necessary for direct DNA contacts (Cho et al., 1994) . All p53 target genes contain versions of the consensus sequence shown above however the location of the consensus relative to the initiation start site diers for each target gene. While many of the p53 induced gene products have been identi®ed to inhibit cell growth by signaling for either growth arrest or apoptosis (including p21/Waf1, Bax and Gadd45), in contrast a growth activating and transforming function has been associated with the product of the mouse double minute 2 (mdm2) gene (reviewed by Ko and Prives, 1996) .
The MDM2 protein is able to form a protein ± protein interaction with p53 which inactivates the transactivation function of p53 (Brown et al., 1993; Haines et al., 1994; Momand et al., 1992; Oliner et al., 1993; Wu et al., 1993) and also targets p53 for degradation (Haupt et al., 1997; Kubbutat et al., 1997) . Overexpression of MDM2 can inhibit the ability of p53 to suppress transformation (Finlay, 1993) as well as inhibit the ability of p53 to evoke cell cycle arrest or induce apoptosis (Chen et al., 1996) . Such abrogation of p53 function by MDM2 is one of the ways MDM2 exerts its oncogenic eect (Oliner et al., 1992; Chen et al., 1996) . The mdm2 gene contains a p53 dependent promoter (P2) in addition to a p53 independent promoter (P1) (Juven et al., 1993; Perry et al., 1993; Wu et al., 1993) . The mdm2 P2 promoter is localized in the ®rst intron of the gene and contains two p53 REs (Juven et al., 1993; Wu et al., 1993; Zauberman et al., 1995) . Mdm2 de®ciency results in embryonic lethality which can be rescued by deletion of the p53 gene (Montes de Oca Luna et al., 1995; Jones et al., 1995) . This demonstrates that the feedback loop between p53 and MDM2 during normal development is critical. Overexpression of MDM2 in tumors is achieved by dierent mechanisms which include increased transcription (Sheikh et al., 1993) , enhanced translation He et al., 1994) , gene ampli®cation (Oliner et al., 1992; Refenberger et al., 1993) and gene rearrangements (Leach et al., 1993) . The fact that wild-type p53 is involved in the control of mdm2 transcription suggests that transcriptional activation from the p53 REs in the mdm2 gene may be dierentially regulated from those target genes whose products signal for growth inhibition.
The regulation of p53 binding to dierent target genes and thus dierent p53 response elements (p53 REs) has been studied predominantly using naked DNA (el-Deiry et al., 1993; Funk et al., 1992; Juven et al., 1993; Kastan et al., 1992; Ko and Prives, 1996; . However the cellular transcription machinery is designed to function with chromatin not naked DNA (reviewed in Felsenfeld, 1996; Kingston et al., 1996) . Recently histone acetylases and histone deacetylases have been shown to regulate transcription by recon®guring chromatin (Wole, 1996; Taunton et al., 1996; Brownell et al., 1996; Wole and Pruss, 1996) . The diversity that exists between p53 target genes suggests that the locations of the p53 REs within chromatin may play a role in the dierential activation of the target genes. We have investigated the interaction of p53 with the mdm2 P2 promoter in chromatin. Basal transcription of the mdm2 gene occurs from the P1 promoter and not the P2 promoter, and p53 is the only transcription factor which has been identi®ed to transactivate mdm2 (Juven et al., 1993; Wu et al., 1993; Zauberman et al., 1995) .
The speci®c nucleotides which are protected by p53 in either the naked or chromatin localized mdm2 gene have not been determined. Recently one study examining the in vivo binding ability of p53 has been reported (Chin et al., 1997) . However in this study the authors were unable to detect any p53 dependent protection changes at the mdm2 gene. We have examined the in vitro interaction of puri®ed p53 with naked mdm2 DNA sequence as well as the intranuclear interaction of p53 with the p53 dependent promoter region of the mdm2 gene. We have observed clear intra-nuclear protection by comparing the genomic DNase I protection patterns of the P2 promoter in two dierent cell lines, a p53-null cell line (10-1) and a temperature-sensitive p53-Val135 overexpressing line (3-4). Nucleosomes are known to repress gene activation by blocking critical DNA sequence elements. Genes localized in repressed chromatin regions can be activated by disruption of nucleosomes positioned over important regulatory regions. In contrast, some genes have regulatory regions which are maintained in a nucleosome-free state allowing the genes to be primed for transcriptional activation (Felsenfeld, 1992) . We have shown (using indirect Southern blot analysis in conjunction with ligation mediated PCR footprinting) that the mdm2 promoters are nucleosome free and that chromatin reorganization is not required for the intra-nuclear p53 dependent protection of the mdm2 P2 promoter. This suggests that a control mechanism exists to maintain the mdm2 gene in a con®guration which is readily accessible for transcriptional activation.
Results
Simultaneous intra-nuclear protection of the p53-REs and the TATA box Ligation mediated PCR genomic footprinting was used to de®ne the nucleotide sequences in chromatin protected in a p53 dependent manner. We compared the protection pattern at the mdm2 P2 promoter in the p53-null cell line (10-1) to that in the ts p53-Val135 containing cell line (3-4). Striking protection of the p53-REs was observed in nuclei of 3-4 cells maintained at 328C for 4 h ( Figure 1a , lane 8; the protected regions are shown by the brackets on the right while the putative p53-REs are shown on the left). While no changes were observed between the protection patterns at p53 RE-1 or p53 RE-2 in 3-4 cells maintained at 398C or 378C, after incubation at 328C for 4 h the 3-4 cells showed protection of the downstream 3' halves of both putative p53 binding sites (Figure 1a , compare lanes 2, 4 and 8). After 2 h of incubation at 328C slight dierences in protection of the P2 promoter in the 3-4 cells emerged, but these changes were not as dramatic as those which occurred after 4 h at 328C (Figure 1a , compare lanes 6 and 8). Additionally, a change in protection at the TATA box region was clear at the 4 h incubation time point (Figure 1a , lane 8 indicated by bracket with *). The DNase I hypersensitive site which emerged (marked *) was also visible in the naked DNA sample (Figure 1a , lane 12) indicating that at the other time points this region may be protected by a factor. It has been shown that p53 and TFIID are able to bind cooperatively to DNA (Chen et al., 1993b) . The simultaneous change in protection at the p53-REs and the TATA box suggests that binding of p53 facilitates recruitment of TFIID to the promoter region. DNA anity chromatography using the mdm2 p53 binding site region without the TATA box has demonstrated p53 dependent recruitment of TBP when comparing 10-1 and 3-4 nuclear extracts (Molina and Bargonetti, unpublished) which further supports the idea of p53 mediated TFIID recruitment. The 3-4 cells shifted to 328C for 24 h showed reduced protection of the two p53-REs with concomitant extended protection over the 3' adjacent TATA box region ( Figure 1a , lane 10). The pattern of genomic protection in 10-1 and 3-4 cells was similar (although not identical) at 398C and 378C ( Figure 1a , lanes 1 ± 4). Changes in the 10-1 protection pattern were observed at 328C but these changes did not correlate with the putative p53-REs. The areas of genomic protection evident in the 3-4 cells after 4 h at 328C overlapped with (but did not completely contain) the predicted p53 sequence recognition elements. Figure 1b shows the oligonucleotides used for LM-PCR footprinting and the mdm2 P2 promoter sequence. The areas of predicted protection are contrasted with the regions which showed p53 dependent changes in the chromatin protection pattern. PhosphorImager analysis of a Northern blot of the mdm2 mRNA produced after 4 h of incubation at 328C indicated that the protection at the p53-REs and the TATA box correlated with a 16-fold increase in transcription (Figure 2 ). p53 mediated DNase I protection of the mdm2 p53-REs is dierent on naked DNA We examined the in vitro DNase I footprinting ability of puri®ed p53 on the mdm2 P2 promoter region of naked DNA in order to determine if the pattern of protection at the p53-REs was the same in vitro and in vivo (Figure 3) . Surprisingly, the in vitro protection pattern demonstrated with puri®ed p53 on naked DNA diered considerably from the p53 dependent genomic protection pattern. Immunopuri®ed p53 on naked DNA protected the 5' half of p53-RE1 and showed no clear protection of p53-RE2, although an adjacent area of protection was identi®ed (Figure 3 , lanes 1 and 2). The footprinting pattern with puri®ed p53 demonstrated a pattern of protection in which p53 binds nucleosome free mdm2 promoter G Xiao et al Figure 1 Ligation-mediated PCR in vivo footprinting demonstrates p53 mediated protection of the p53-REs. (a) The published p53-REs and adjacent TATA box were identi®ed by sequencing the subcloned genomic mdm2 (a generous gift from Donna George) (lanes are indicated as ATGC). The DNase I treated samples were prepared from nuclei of either 10-1 or 3-4 cells maintained at 398C (lanes 1 and 2), 378C (lanes 3 and 4), 328C for 2 h (lanes 5 and 6), 328C for 4 h (lanes 7 and 8) and 328C for 24 h (lanes 9 and 10). Puri®ed DNA from undigested nuclei is shown in lane 11 and naked mouse genomic DNA digested with DNase I is shown in lane 12. Ligation mediated PCR was carried out followed by primer extension with sequences extending from the speci®c site were alternately protected and hypersensitive to DNase I cutting; this is consistent with our previous observations with puri®ed p53 at other p53 binding sites . The auxilary protection may be a result of p53 protein multimers wrapping around the DNA (Stenger et al., 1994) . The dierence between the genomic footprinting pattern and the in vitro protection pattern suggests that the chromatin structure of the mdm2 gene organizes the P2 promoter region of DNA into a sequence which is an optimal p53 DNA binding site. Another possibility for the increased binding of p53 to chromatin is that posttranslational modi®cations of p53 in the nucleus facilitated p53 binding to the genomic mdm2 chromatin.
The mdm2 P1 and P2 promoters are constitutively nucleosome free
When genes controlled by speci®c promoters are transcriptionally active, or are primed to be activated, their promoter regions in chromatin are marked by increasing sensitivity to DNase I which results from disruption of nucleosomes (Gross and Garrard, 1988; Weintraub and Groudine, 1976) . We took advantage of this fact and screened for the appearance of p53 dependent DNase I hypersensitive sites at the mdm2 P2 promoter. We examined by indirect endlabeling analysis the genome from isolated DNase I treated nuclei of 10-1 or 3-4 cells maintained at 378C, 328C for 4 h or 328C for 24 h (Figure 4a ± c).
Interestingly the same two DNase I hypersensitive sites were evident in both the 10-1 and 3-4 cell lines at the dierent temperature shift points indicating that p53 did not induce nucleosome positioning changes. One hypersensitive site was observed 2.2 kb from the EcoRI cutting site which corresponded to the mdm2 P1 promoter region ( Figure 4a , indicated by the P1 arrow) while the other was observed 1.5 kb from the EcoRI cutting site which corresponded to the location of the P2 promoter region (Figure 4a , indicated by the P2 arrow). The overall DNase I sensitivity of these two sites did not change in the presence of wild-type p53 over the course of a 24 h temperature shift to 328C (Figures 4b and c) . The constitutive nature of the hypersensitive site at the mdm2 P2 promoter indicated that this region was maintained as an altered chromatin structure in the absence of p53 ( Figure 4a ). To further analyse the nucleosome arrangement we assayed the micrococcal nuclease sensitivity of the p53 dependent mdm2 P2 promoter. Although ethidium bromide staining of the agarose gel showed the expected nucleosome fragmentation ladder Southern blotting of both the 10-1 and 3-4 genomes with a P2 promoter speci®c probe gave a barely detectable smearing signal without a nucleosome ladder (data not shown). Taken together these results further support that the P2 promoter region was constitutively nucleosome-free.
Increased p53 protein levels correlate with the genomic footprint
Previous reports on the properties of ts p53-Val135 have shown increased levels of nuclear p53 protein when the cells are shifted to 328C (Martinez et al., 1991) . In order to determine if the genomic protection of the mdm2 p53-REs corresponded to an increase in nuclear p53 we analysed the nuclear level of p53 at the dierent temperature shift time points ( Figure 5 ). A twofold increase in the nuclear p53 level was observed when the cells had been maintained at 328C for 4 h ( Figure 3 DNase I protection of the p53-REs of mdm2 in vitro diers from that observed in vivo. In vitro footprinting of a naked mdm2 DNA fragment with puri®ed p53. The published p53-REs and adjacent TATA box were identi®ed by sequencing genomic mdm-2 in a plasmid clone (lanes indicated as ATGC) and are indicated on the left. Increasing amounts of puri®ed p53 were added to a complete ApaI ± XhoI digest of the naked mdm2 genomic plasmid clone (lanes 1 and 2, as indicated). Footprints were visualized by primer extension using 32 P-labeled oligonucleotide #3 which hybridized 350 bp downstream from the TATA box. Lane 3 contains no p53 protein p53 binds nucleosome free mdm2 promoter G Xiao et al at least partially explains the dynamic intranuclear footprint that was observed. All lanes on the gel were normalized for the same amount of total protein. We subsequently demonstrated equivalent levels of protein in all samples by stripping the gel and Western blotting with an antibody to the ubiquitous transcription factor Sp1 (data not shown). Interestingly, this increased level of nuclear localized wild-type p53, in addition to the concomitant nuclear chromatin binding did not initiate additional DNase I hypersensitive sites (Figure 4b ).
EMSA with nuclear extract containing p53-Val135 shows possible p53 mediated recruitment of other factors to the mdm2 DNA site
It has been demonstrated that p53 can bind differentially to p53-REs that contain variations of the p53 consensus binding sequence. Phosphorylation of the Cterminal end of p53 as well as addition of the p53 speci®c antibody PAb421 are able to activate p53 DNA binding activity (Hupp et al., 1992; Funk et al., 1992; Halazonetis et al., 1993; Hecker et al., 1996; Takenaka et al., 1995; Wang and Prives, 1995) . We examined the p53 dependent gel shift of an oligonucleotide containing the mdm2 P2 p53-REs using a standard electrophoretic mobility shift assay (EMSA). No p53 dependent gel shift species were observed in either the absence or presence of the p53 speci®c antibody PAb421 when examining nuclear extract from 10-1 or 3-4 cells maintained at 378C (Figure 6a , compare lanes 1 and 2 to lanes 7 and 8). A striking p53 dependent gel shift of the mdm2 oligonucleotide was observed in the presence of PAb421 with nuclear extract derived from 3-4 cells maintained at 328C for 4 h, while the corresponding 10-1 nuclear extract showed no p53 dependent gel shift species (Figure 6a , The mdm2 P1 and P2 promoters are constitutively nucleosome free. DNA in 2610 6 isolated nuclei was digested with increasing amounts of DNase I (0 mg, 0.1 mg, 0.5 mg, 2 mg, 8 mg or 16 mg as indicated above each lane). Nuclei were isolated from 10-1 and 3-4 cells maintained at 378C (a), 328C for 4 h (b) or 328C for 24 h (c). The ethidium stained agarose gel of b is also shown (d). Puri®ed DNA was restricted with EcoRI and electrophoresed on a 0.8% agarose gel, probed with a 32 P-labeled EcoRI ± XhoI genomic mdm2 probe fragment (shown in e). The arrows indicate the hypersensitive sites in the mdm2 gene. (e) Physical map of the upstream region of the murine mdm2 gene (Barak et al., 1994) . The * delineates the location of the p53 REs p53 binds nucleosome free mdm2 promoter G Xiao et al compare lanes 3 and 4 to lanes 9 and 10; the shift is indicated by the arrow on the left). Nuclear extract derived from cells maintained at 328C for 24 h gave a reduction in the p53 dependent gel shift species and this also corresponded to the decreased level of p53 protein shown by Western blot analysis (Figure 6a , compare lanes 10 and 12). The gel shift complex observed in the presence of immunopuri®ed p53 and PAb421 migrated faster than the species from crude nuclear extracts (Figure 6b ). It is possible that the dierent source of p53 in¯uenced the gel migration. However a comigrating PAb421 induced supershift species was evident from reactions containing 3-4 nuclear extract and puri®ed p53 when a super consensus site sequence (SCS) oligonucleotide was used for the EMSA (data not shown). Together these data suggest that either additional proteins from the nuclear extract sample are complexed with the mdm2 oligonucleotide or that dierent post-translationally modi®ed forms of p53 bind to the SCS and mdm2 oligonucleotides.
A competition gel shift assay was carried out to further support the speci®city of the p53 binding to the mdm2 oligonucleotide. The PAb421 induced supershift from the 328C 4 h nuclear extract sample was competed away with both non-radioactive mdm2 oligonucleotide as well as with an oligonucleotide containing the p53 super consensus site sequence (SCS) (Figure 6b , lanes 1 ± 5) while a mutant p53 binding site oligonucleotide was unable to compete away this p53 dependent gel shift species (Figure 6b , lanes 6 and 7). This result was analogous to that 10x  50x  10x  50x  10x  50x  -10x  50x  10x  50x  10x  50x   MDM2  SCS  mut  MDM2  SCS  mut 3-4 32°C 4hr+ 421 Ab wt p53+421 Ab b a 1 2 3 4 5 6 7 8 9 10 11 12 13 14 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Figure 6 Protection of the mdm2 P2 promoter in vivo corresponds to the enhanced binding of nuclear p53 to an mdm2 P2 oligonucleotide. (a) EMSA of a mdm2 P2 containing oligonucleotide with 2 mg of 10-1 (lanes 1, 3, 4, 5, 7, 9 and 11) or 3-4 nuclear extracts (lanes 2, 4, 6, 8, 10 and 12) in the absence (lanes 1 ± 6) or presence of PAb 421 (lanes 7 ± 12). Lanes 13 and 14 contain puri®ed wild-type p53. (b) EMSA of mdm2 P2 containing oligonucleotide with 2 mg of 3-4 nuclear extracts (lanes 1 ± 7) and 150 ng of puri®ed wild-type p53 (lanes 8 ± 14) in the presence of PAb 421. Competition was carried out with 10 and 50 fold excess of either mdm2 oligonucleotide (lanes 2, 3, 9 and 10), p53 super consensus sequence (lanes 4, 5, 11 and 12) or mutant RGC oligonucleotide (lanes 6, 7, 13 and 14). The arrows indicate the nuclear extract derived p53 dependent gel shift species p53 binds nucleosome free mdm2 promoter G Xiao et al obtained using immunopuri®ed wild-type p53 ( Figure  6b , lanes 8 ± 14); except for the fact that the samples containing immunopuri®ed p53 produced a markedly faster migrating gel shift species in EMSA than the nuclear extract.
Discussion
Studies on the ability of p53 to bind to DNA have been carried out predominantly in vitro, but little is known about the ability of the protein to bind to speci®c target sites in vivo (Chin et al., 1997) . The region of the mdm2 gene with which p53 interacts was originally identi®ed by co-immunoprecipitation of a speci®c DNA element as well as by demonstrating a minimal sequence able to confer p53 speci®c transactivation of a reporter construct (Juven et al., 1993; Wu et al., 1993) . The nucleotides within this region that are speci®cally bound by p53 and thereby protected from DNase I digestion were not identi®ed. Using ligation mediated PCR intra-nuclear footprinting, we have shown clear protection of sequences within the p53 REs in the mdm2 gene. This protection was dynamic and occurred after a 4 h 328C temperature shift of the 3-4 cells. A 16-fold activation of mdm2 transcription was also noted at this time point. Therefore, it is not surprising that the footprinting pattern demonstrated protection of the TATA box region as well. It is clear that the pattern of protection at both the p53-REs and the TATA box region showed dramatic dierences in the 3-4 cells maintained at 328C for 4 h when compared to the 3-4 cells maintained at 398C or 378C. Interestingly the in vitro p53 protection pattern of the naked mdm2 DNA sequence did not correlate well with the putative p53 REs. Immunopuri®ed p53 protected only one of the two p53 REs on naked DNA. p53 dependent intra-nuclear protection, on the other hand, showed a correlation between the protected regions and the two putative p53 REs. There are a number of possible explanations for these results. First the chromatin structure of the mdm2 gene may facilitate the binding of p53. Second, posttranslational modi®cations of p53 in the nucleus may facilitate the binding of p53 to the mdm2 sequence. Finally, protein ± protein interactions may be functioning to recruit p53 to the mdm2 chromatin region. The p53 consensus DNA binding sequence consists of two functional half-sites . These half sites can be separated by 0 ± 13 bp but p53 binds separated half sites best when they are centered on the same face of the DNA helix . The p53-DNA crystal structure indicates that the core domain binds primarily to a single pentamer consensus (ie. Pu Pu Pu C A/T) (Cho et al., 1994) . The mdm2 P2 promoter in both humans and mice contains two consensus p53-REs and each has two contiguous half sites (i.e. four pentamers) (Zauberman et al., 1995) . Thus the fact that the protection pattern does not completely cover both p53 REs is not surprising. Interestingly, deletion of one of the mdm2 p53-REs virtually abolishes the ability of p53 to transactivate a promoter reporter construct (Zauberman et al., 1995) . It has been suggested that the mdm2 P2 promoter region may contain two relatively weak p53 binding sites as a means of preventing premature activation (Zauberman et al., 1995) . DNA binding by p53 oligomers as well as p53 mediated DNA looping are linked with transcriptional activation (Stenger et al., 1994) . DNA looping at the mdm2 P2 promoter may be facilitated (and necessary) in the presence of the two p53-REs by using a half site from each. The fact that the nuclear extract derived p53-mdm2 oligonucleotide gel shift species migrated more slowly than the puri®ed p53 gel shift species suggested that other nuclear proteins were associated with the p53-DNA complex. The diculty obtaining a clear in vitro footprint of the mdm2 p53 REs may have resulted because a speci®c chromatin con®guration is needed to facilitate p53 binding. Extended areas of protection and hypercutting resulted in the presence of puri®ed p53 which may have been due to the p53 wrapping around the DNA in the absence of other nuclear proteins. It is possible that p53 requires additional nuclear proteins in order to eciently bind to the mdm2 DNA sequence. TFIID and p53 bind cooperatively to DNA (Chen et al., 1993) and the redox protein Ref-1 has been shown to activate the DNA binding ability of p53 (Jayaraman et al., 1997) . The mdm2 P2 promoter may be an example of a promoter where p53 will bind eciently only in the presence TFIID and other protein factors. We are investigating this possibility.
Although the ligation mediated footprint resulting in the 3-4 cells maintained at 328C for 24 h did not show protection of the p53 REs, some p53 dependent DNA binding was observed by EMSA with nuclear extract derived from these cells. This suggests that p53 may be tethered to the complex via association with other DNA bound proteins. In a recent study the relative instability of p53-DNA interactions in vivo has been noted (Chin et al., 1997) . In fact the authors were unable to explain their complete lack of an in vivo footprint at the mdm2 gene. The reason why we were able to see a protection pattern and they were not may be explained by the dierent cell systems used. In the case of the murine cell line used for the experiments presented here the MDM2 levels must be maintained low enough for the cells to undergo a cell cycle arrest (as this is the phenotype for the 3-4 cells at 328C). Alternatively regulatory mechanisms may exist to maintain p53 activity which functions to arrest cell growth. The human ML-1 cell line used by Chin et al., normally undergoes apoptosis in response to the activation of wild-type p53 by DNA damage (Nelson and Kastan, 1994) . The p53 in the 3-4 cell line and the p53 in the ML-1 cell line may contain dierent posttranslational modi®cations.
Constitutive hypersensitive sites are often present in promoter regions of genes poised for transcriptional activation and these sensitive sites exist independent of gene expression (Gross and Garrard, 1988) . Using DNase I hypersensitive site mapping of the mdm2 gene we have identi®ed two DNase I hypersensitive sites which localized at both the P1 and P2 promoters of the mdm2 gene. Chromatin structure has been shown to regulate gene expression. The data presented here show that the mdm2 gene is a member of the class of genes which exist in a preferentially DNase I sensitive state. This suggests that the mdm2 gene is primed for both transcriptional activation and repression (Gross and Garrard, 1988) . The two DNase I hypersensitive sites p53 binds nucleosome free mdm2 promoter G Xiao et al occurred in both the presence and absence of p53. No changes in mdm2 DNase I hypersensitivity resulted when p53 bound to the P2 promoter. Our results suggest that a mechanism exists in order to maintain the mdm2 gene in a con®guration which is readily accessible for the binding of protein factors, one of which is p53.
p53 is a nuclear phosphoprotein and the DNA binding activity of p53 can be activated by phosphorylation of the protein's C-terminal domain (reviewed in Ko and Prives, 1996) . Recently it has been shown that the C-terminal domain of p53 can be acetylated by its co-activator p300 and that this posttranslational modi®cation activates the DNA binding activity of p53 . Interestingly p300/CBP and p53 can synergistically activate transcription of a transiently transfected construct containing the mdm2 P2 promoter . The DNase I sensitivity studies presented here demonstrate that activation of the mdm2 gene does not require chromatin remodeling. Taken together these ®ndings suggest that the acetyltransferase p300 activates p53-mediated mdm2 transcription by direct acetylation of p53 and not via the modi®cation of histones. In light of the fact that p53 and p300 co-localize within the nucleus and coexist in a stable DNA-binding complex (Lill et al., 1997) it is possible that the acetyltransferase p300 functions dierently at a wide array of p53 target sites dependent upon the chromatin con®guration of each gene.
It has been reported that chain elongation by RNA polymerase II is unimpeded by the presence of one or two histone octamers in its path in vitro. When longer arrays of octamers are present, pol II is still able to elongate RNA in vitro, but transcription is partially inhibited by pausing along the template. This eect may well be alleviated in vivo by histone modi®cation or the presence of additional factors (Felsenfeld, 1992 ). Since we did not ®nd other DNase I hypersensitive sites downstream of the mdm2 gene TATA box in either the 328C 4 h or 24 h samples, we would like to suggest that drastic disruption of the nucleosomes does not occur during elongation. Our results suggest that the chromatin structure of the mdm2 gene may be important for regulation of gene expression by p53 and other factors. This would not be surprising in light of the fact that the mdm2 gene is an essential gene for mouse development and thus transcriptional activation and repression of the mdm2 gene must be rapidly coordinated (Montes de Oca Luna et al., 1995) . It is possible that nucleosome free chromatin structures are not present in all p53 REs. For example the chromatin remodeling histone transacetylase p300/CBP has been shown to bind to and modulate p53 activity at both the p21/WafI and Bax DNA binding elements (Lill et al., 1997; Avantaggiati et al., 1997) and the p53 response elements of these genes may be localized in repressed chromatin. In p53 regulated genes where the protein product negatively regulates cell cycle progression nucleosome disruption and chromatin remodeling may be required as a part of the transcriptional control mechanism; this would most likely involve the recruitment of a histone transacetylase. Most of the identi®ed genes activated by p53 negatively regulate cell growth while mdm2, in contrast, positively regulates cell cycle progression. We postulate that chromatin structure is one of the mediators which regulates p53 recognition of binding sites during the course of the cell cycle and therefore chromatin structure may act as a modulator of p53 driven gene activation. Further studies are in progress to investigate these possibilities.
Materials and methods

Cells and viruses
The 10-1 cell line is a mouse ®broblast cell line lacking endogenous p53 protein due to a deletion of the p53 gene (Martinez et al., 1991) . 10-1 cells were co-transfected with the temperature-sensitive mutant p53-Val135 plasmid (pLTRp53cGval135) (Michalovitz et al., 1990 ) and a Neomycin resistant plasmid to create a stable p53 expressing cell line called 3-4 (Chen et al., 1995) . Spodoptera frugiperda cells (Sf21 cells) and the recombinant baculoviruses expressing wild-type human p53 were as described (O'Reilly and Miller, 1988) . Sf21 cells were grown at 278C in TC-100 medium (GIBCO) containing 10% heat-inactivated fetal bovine serum.
DNase I treatment of nuclei
10-1 and 3-4 cells were grown on 150 mm plates at 378C in Dulbecco's Modi®ed Eagle Medium (GIBCO) containing 10% heat-inactivated fetal bovine serum (GIBCO) until 80% con¯uence. Sub-con¯uent plates were shifted to either 398C for 18 h, 328C for 4 h or 328C for 24 h. The cells were washed twice with 48C 16PBS, scraped o the plate and spun down at 2500 r.p.m. (48C) for 10 min. The pellet was resuspended in 2 ml of RSB per plate (10 mM Tris-HCl pH 7.4; 10 mM NaCl; 3 mM MgCl 2 pH 7.4; 0.5% NP ± 40) with 1 mM PMSF. The cells were homogenized 30 ± 40 strokes and checked by trypan blue exclusion. Nuclei were isolated by centrifugation at 4000 r.p.m. at 48C for 10 min and washed once with RSB. 2.0610 6 nuclei in 250 ml of RSB were treated with increasing amounts of DNase I (Worthington; 2932 units/mg) for 10 min at either 378C or 328C. The reactions were stopped by adding 250 ml of DNase I stop buer (2 M NH 4 OA c ; 100 mM EDTA; 0.2% SDS) followed by proteinase K digestion overnight at 378C at a ®nal concentration of 400 mg/ml. The DNA was extracted once with phenol and three times with chloroform followed by ethanol precipitation.
DNA and RNA blot analysis 20 mg of DNase I treated genomic DNA was digested to completion with EcoRI (GIBCO). The digested DNA was electrophoresed on a 0.8% agarose gel (GIBCO) overnight at 23 V and transferred to positively charged nylon membrane (Schlelcher and Schuell) by electro-transfer at 0.1 Amp overnight at 48C. Cytoplasmic RNA was isolated from 10-1 and 3-4 cells according to Maniatis. Poly(A) + RNA was prepared using mini-oligo dT spin columns (5' Prime?3' Prime, Inc.). 1.5 mg of poly(A) + RNA from each sample was electrophoresed on a 1% formaldehyde-agarose gel and transferred onto positively charged membrane as described above. The membranes were baked at 808C for 2 h and U.V. crosslinked. The murine mdm2 1.1 kb probe for Southern blot was obtained as a EcoRI ± XhoI fragment from a genomic subclone (Juven et al., 1993) . The murine mdm2 400 bp probe which contain exon 2 was digested with NsiI ± ApaI for Northern blot. The GAPDH probe was obtained as a 1.25 Kb cDNA PstI fragment (Marty et al., 1985) . All probes were labeled with 32 P-dCTP by p53 binds nucleosome free mdm2 promoter G Xiao et al random prime labeling (Boehringer Mannheim). The speci®c activity for all the probes used was at least 10 8 c.p.m./mg.
Ligation-mediated PCR for in vivo footprinting
The ligation-mediated PCR footprinting technique carried out was an adaptation of that ®rst described by Mueller and Wold (1989) and later revised by (McPherson et al., 1993) . The ®rst step of the reaction was carried out in a volume of 15 ml containing 1 mg of genomic DNA derived from nuclei treated with 0.1 mg of DNase I, 16Sequenase buer 1 (25 mM Tris-HCl pH 7.5; 80 mM NaCl; 0.5 mM MgCl 2 ) and 1 ml of 0.3 pmol/ml oligo #1 (5'-TCGAGGTAGAAATACCAACC-3'). The mixture was denatured at 958C for 5 min and annealed at 508C for 30 min then chilled on ice. 9 ml of Sequenase buer 2 (40 mM Tris-HCl pH 7.5; 5 mM MgCl 2 ; 20 mM DTT; 0.1 mM dNTPs) and 0.5 ml Sequenase DNA Polymerase, version 2.0 (USB, 13 U/ml) were then added and the mixture was incubated at 378C for 10 min followed by inactivation of the enzyme at 688C for 10 min. The ligation was carried out by adding 20 ml of Ligase buer 1 (80 mM Tris-HCl pH 7.5; 180 mg/ml BSA; 30 mM MgCl 2 , 20 ml of Ligase buer 2 (12 mM ATP; 70 mM DTT), 5 ml Linker solution (20 pmol/ml of 5'-GAATT-CAGATC-3' (LMP-T1) and 3'-CTTAAGTCTA-GAGGGCCCAGTGGCG-5' (LMP-B1) in 250 mM TrisHCl pH 7.5; 5 mM MgCl 2 ) and 3 ml of T4 DNA Ligase (GIBCO, 1 Weiss unit/ml) followed by incubation at 208C overnight. The DNA was ethanol precipitated and resuspended in 14 ml of dH 2 O. Additional components were then added for PCR reactions as follows: 16 ml of 2.5 mM dNTP, 2 ml of 5 pmol/ml oligo #2 (5'-CGAAGCTGGAATCTGTGAGG-3'), 2 ml of 5 pmol/ml LMP-T1, 1 ml of 4 mg/ml BSA, 4 ml of 106Taq buer (650 mM Tris-HCl pH 8.8; 100 mM b-mercaptoethanol; 165 mM (NH 4 ) 2 SO 4 ; 15 mM MgCl 2 ) and 0.5 ml of Taq DNA polymerase (Boehringer Mannheim 5 U/ml). The samples were cycled 25 times by denaturation at 948C for 1 min, annealing at 658C for 2 min and extension at 748C for 3 min. The PCR products were prepared for visualization using polynucleotide kinase (New England Biolabs) [ 32 P] radiolabeled oligo #3 (5'-GGAATCTGT-GAGGTGCTTGCAGCA-3') for primer extension. 1.5 ml of [ 32 P] oligo #3 (1 pmol/ml) was aded to 15 ml of PCR reaction product along with 0.5 ml of 106Taq buer, 3 ml of 2.5 mM dNTPs and 0.5 ml Taq DNA polymerase. Seven PCR cycles of denaturation at 948C for 1 min, annealing at 688C for 2 min and extension at 748C for 3 min were carried out and then 30 ml stop mixture (24 ml TE; 1 ml of 5 mg/ml tRNA; 5 ml of 3M N a OAc) was added, followed by chloroform extraction and ethanol precipitation. The pellet was resuspended in 12 ml of sequencing loading buer and the sample was electrophoresed on a 6% denaturing polyacrylamide gel. DNA sequencing reactions were carried out using oligo #3 and Sequenase DNA Polymerase, version 2.0 (USB, 13 U/ml).
Western blot analysis Nuclear lysates were prepared from cells maintained as described above. The cells were washed two times with 48C 16PBS. Cytoplasmic lysis buer was prepared with 8.8 ml of lysis buer stock (20 mM HEPES pH 7.5, 20% Glycerol, 10 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA pH 8.0, 0.1% Triton X-100, 1 mM DTT, 1 mM PMSF, 50 mg/ml aprotinin, 50 mM leupeptin) and 6.2 ml of ddH 2 O. Two milliliters of cytoplasmic lysis buer were added to each washed 150 mm plate. The cells were scraped o the plate and spun at 2300 r.p.m. at 48C for 7 min. The supernatant was removed and the pellet was resuspended in 1 ml of nuclear extraction buer (prepared with 8.8 ml of lysis buer stock, 0.5 M NaCl, and 4.7 ml of ddH 2 O). The cells were rocked with the nuclear extraction buer for 1 h at 48C and then centrifuged at 14 000 r.p.m. for 5 min to extract the nuclear proteins. The supernatant was removed and the pellet was discarded. Protein concentrations of the extracts were determined via Bradford Microassay (BIORAD). Samples were electrophoresed on a 10% SDS ± PAGE and electro-transferred to nitrocellulose. The blot was probed with a mixture of monoclonal antibodies speci®c to p53 (PAbs 1801, 240 and 421) and after incubation with goat anti-mouse secondary antibody was visualized using ECL solutions (Amersham).
Puri®cation of p53 proteins Sf21 cells (2.5610 7 /150 mm dish) were infected with recombinant baculovirus and harvested 48 h post infection. Extracts of infected cells were prepared and p53 proteins were puri®ed from cell lysates by PAb421 immunoanity procedures as described . Two dierent preparations of protein were produced one was eluted with ethylene glycol and the other was eluted with p53 peptide (KKGQSTSRHKK-OH) (Bargonetti et al., 1993) ; both were dialyzed into a buer containing 10 mM HEPES (pH 7.5), 5 mM NaCl, 0.1 mM EDTA, 1 mM DTT and 50% glycerol. Ethylene glycol eluted protein was used for EMSAs and peptide eluted protein was used for in vitro footprinting.
EMSA The MDM2 synthetic oligonucleotide used in this study, obtained from Operon, contained two p53 response elements. The sequence of this oligonucleotide was the following: 5'-GAT CCC TGG TCA AGT TGG GAC ACG TCC GGC GTC GGC TGT CGG AGG AGC TAA GTC CTG ACA TGT CTC CG-3'. The SCS synthetic oligonucleotide used in this study, also obtained from Operon, contained one consensus p53 binding site. The sequence of this oligonucleotide was the following: 5'-TCG AGC CGG GCA TGT CCG GGC ATG TCC GGG CAT GTC-3'. The mutant oligonucleotide used was derived from the RGC sequence and was the following: 5'-TCGAGTT-TAATGGACTTTAATGGCCTTTAATTC-3'. Labeling of the oligonucleotides was performed with the large fragment of DNA polymerase and 32 P-dCTP. Reaction mixtures for EMSA experiments (30 ml) were carried out with 0.1 pmoles of oligonucleotide, 0.5 mg salmon sperm DNA, 1 mM DTT, 1 mM EDTA pH 8.0, 100 mM KCl, 20 mM HEPES pH 7.8 and 10% Glycerol. In addition to 2 mg of 10-1 or 3-4 nuclear protein extract, 1 mg of PAb 421 was added to the designated reactions. In the reactions with puri®ed p53 150 ng of protein was added. All samples were incubated at room temperature for 30 min. The protein ± DNA complexes were resolved on a 4% acrylamide gel which was pre-run at 100 V at 48C for 2 h prior to loading and samples were then electrophoresed at 200 V for 3 h.
Plasmid DNase I footprinting
Reaction mixtures for plasmid footprinting (50 ml) were carried out with 25 ng of the genomic sublcone digested with XhoI and ApaI in the presence of 1 mg of BSA, in 2 mM Spermidine, 0.9 mM DTT, 2 mM MgCl2, 0.1 mM EDTA pH 8.0, 25 mM KCl, 20 mM HEPES pH 7.5 and 10% Glycerol. Increasing amounts of p53 were added as indicated in the ®gure legend and the reaction mixture was incubated on ice for 30 min followed by digestion with 2 ng of DNase I (Worthington; 2932 units/mg) on ice for 1 min followed by the addition of 50 ml of DNase I stop buer (2M ammonium acetate, 100 mM EDTA, 0.2% SDS, 100 mg/ml sheared salmon sperm DNA. The DNA was phenol and chloroform extracted followed by ethanol precipitation. The pellet was resuspended in 15 ml of dH 2 O followed by primer extension with 32 P-labeled oligo #3 (5'-GGAATCTGTGAGGTGCTTGCAGCA-3'). 1.5 ml p53 binds nucleosome free mdm2 promoter G Xiao et al of 32 P-oligo #3 (1 pmol/ml) was added to the reaction along with 0.5 ml of 106Taq buer, 3 ml of 2.5 mM dNTPs and 0.5 ml Taq DNA polymerase. Seven PCR cycles of denaturation at 948C for 1 min, annealing at 688C for 2 min and extension at 748C for 3 min were carried out and then 30 ml stop mixture (24 ml TE; 1 ml of 5 mg/ml tRNA; 5 ml of 3M NaOAc) was added, followed by chloroform extraction and ethanol precipitation. The pellet was resuspended in 12 ml of sequencing loading buer and the sample was electrophoresed on a 6% denaturing polyacrylamide gel.
